Literature DB >> 24638136

Neuro-oncology: Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma.

Hemi Malkki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24638136     DOI： 10.1038/nrneurol.2014.47

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  2 in total

1.  Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.

Authors:  Olivier L Chinot; Wolfgang Wick; Warren Mason; Roger Henriksson; Frank Saran; Ryo Nishikawa; Antoine F Carpentier; Khe Hoang-Xuan; Petr Kavan; Dana Cernea; Alba A Brandes; Magalie Hilton; Lauren Abrey; Timothy Cloughesy
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

2.  A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245
  2 in total
  4 in total

1.  An overview of neuro-oncology research and practice in Iran, three years with the NOSC initiative.

Authors:  Peiman Haddad; Sohrab Shazadi; Farhad Samiei; Homayoun Hadizadeh Kharrazi; Morteza Tabatabaeefar; Afshin Rakhsha; Mohammad Faranoosh; Mohammad Torabi-Nami; Ali Dadras; Atieh Liaghi; Leila Nafarieh
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  The Microenvironmental Landscape of Brain Tumors.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Cancer Cell       Date:  2017-03-13       Impact factor: 31.743

3.  Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging.

Authors:  Xin Mei; Yin-Sheng Chen; Fu-Rong Chen; Shao-Yan Xi; Zhong-Ping Chen
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

Review 4.  Current treatments for non-small cell lung cancer.

Authors:  Qianqian Guo; Liwei Liu; Zelong Chen; Yannan Fan; Yang Zhou; Ziqiao Yuan; Wenzhou Zhang
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.